Literature DB >> 30952629

Management of Adult Minimal Change Disease.

Stephen M Korbet1, William L Whittier2.   

Abstract

Keywords:  Nephrosis, Lipoid; idiopathic nephrotic syndrome; minimal change disease; relapse; remission; treatment

Year:  2019        PMID： 30952629      PMCID： PMC6556731          DOI： 10.2215/CJN.01920219

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

Review 1.  The treatment of minimal change disease in adults.

Authors:  Jonathan Hogan; Jai Radhakrishnan
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

2.  Minimal-change glomerulopathy of adulthood.

Authors:  S M Korbet; M M Schwartz; E J Lewis
Journal:  Am J Nephrol       Date:  1988       Impact factor: 3.754

3.  Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

Authors:  Piero Ruggenenti; Barbara Ruggiero; Paolo Cravedi; Marina Vivarelli; Laura Massella; Maddalena Marasà; Antonietta Chianca; Nadia Rubis; Bogdan Ene-Iordache; Michael Rudnicki; Rosa Maria Pollastro; Giovambattista Capasso; Antonio Pisani; Marco Pennesi; Francesco Emma; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2014-01-30       Impact factor: 10.121

4.  Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease.

Authors:  Helene Munyentwali; Khedidja Bouachi; Vincent Audard; Philippe Remy; Philippe Lang; Rachid Mojaat; Georges Deschênes; Pierre M Ronco; Emmanuelle M Plaisier; Karine Y Dahan
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

Review 5.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

6.  Long-term Outcome of Adult Onset Idiopathic Minimal Change Disease.

Authors:  S N Colattur; S M Korbet
Journal:  Saudi J Kidney Dis Transpl       Date:  2000 Jul-Sep

7.  Adult-onset minimal change nephrotic syndrome: a long-term follow-up.

Authors:  F Nolasco; J S Cameron; E F Heywood; J Hicks; C Ogg; D G Williams
Journal:  Kidney Int       Date:  1986-06       Impact factor: 10.612

8.  Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.

Authors:  C Ponticelli; A Edefonti; L Ghio; G Rizzoni; S Rinaldi; R Gusmano; G Lama; G Zacchello; R Confalonieri; P Altieri
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

9.  Adult minimal-change disease: clinical characteristics, treatment, and outcomes.

Authors:  Meryl Waldman; R John Crew; Anthony Valeri; Joshua Busch; Barry Stokes; Glen Markowitz; Vivette D'Agati; Gerald Appel
Journal:  Clin J Am Soc Nephrol       Date:  2007-04-11       Impact factor: 8.237
  9 in total
  13 in total

1.  Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.

Authors:  Ryohei Yamamoto; Enyu Imai; Shoichi Maruyama; Hitoshi Yokoyama; Hitoshi Sugiyama; Asami Takeda; Tatsuo Tsukamoto; Shunya Uchida; Kazuhiko Tsuruya; Tatsuya Shoji; Hiroki Hayashi; Yasuhiro Akai; Megumu Fukunaga; Tsuneo Konta; Saori Nishio; Shunsuke Goto; Hirofumi Tamai; Kojiro Nagai; Ritsuko Katafuchi; Kosuke Masutani; Takashi Wada; Tomoya Nishino; Arimasa Shirasaki; Hiroshi Sobajima; Kosaku Nitta; Kunihiro Yamagata; Junichiro J Kazama; Keiju Hiromura; Hideo Yasuda; Makoto Mizutani; Toshiyuki Akahori; Tomohiko Naruse; Takeyuki Hiramatsu; Kunio Morozumi; Tetsushi Mimura; Yosuke Saka; Eiji Ishimura; Hajime Hasegawa; Daisuke Ichikawa; Takashi Shigematsu; Hiroshi Sato; Ichiei Narita; Yoshitaka Isaka
Journal:  J Nephrol       Date:  2022-04-02       Impact factor: 3.902

2.  Minimal Change Disease in an Adult: A Case Report.

Authors:  Shashank Neupane; Prasamsa Pudasaini; Anupam Sharma; Shriya Sharma; Aakriti Adhikari; Kumar Roka
Journal:  JNMA J Nepal Med Assoc       Date:  2022-04-15       Impact factor: 0.556

Review 3.  Interventions for minimal change disease in adults with nephrotic syndrome.

Authors:  Karolis Azukaitis; Suetonia C Palmer; Giovanni Fm Strippoli; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2022-03-01

Review 4.  Podocytopathies.

Authors:  Jeffrey B Kopp; Hans-Joachim Anders; Katalin Susztak; Manuel A Podestà; Giuseppe Remuzzi; Friedhelm Hildebrandt; Paola Romagnani
Journal:  Nat Rev Dis Primers       Date:  2020-08-13       Impact factor: 52.329

5.  Association between diuretic administration before diagnosis and incidence of acute kidney injury in patients with minimal change disease: A single-center observational study.

Authors:  Yoshinosuke Shimamura; Koki Abe; Takuto Maeda; Yayoi Ogawa; Hideki Takizawa; Junichi Ishigami; Kunihiro Matsushita
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

6.  Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series.

Authors:  Hamza Naciri Bennani; Thomas Jouve; Johan Noble; Lionel Rostaing; Paolo Malvezzi; Rachel Tetaz
Journal:  Case Rep Nephrol       Date:  2019-10-09

Review 7.  CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease.

Authors:  Yoong Mond Teh; Soo Kun Lim; Norhana Jusoh; Kahar Osman; Siti Aisyah Mualif
Journal:  Biomed Res Int       Date:  2021-01-06       Impact factor: 3.411

8.  Apheresis in Adult With Refractory Idiopathic Nephrotic Syndrome on Native Kidneys.

Authors:  Léa Moret; Alexandre Ganea; Myriam Dao; Aurélie Hummel; Bertrand Knebelman; Jean François Subra; Johan Noble; Christophe Mariat; Noémie Jourde-Chiche; Fatouma Toure; Cyril Garrouste; Charlotte Laurent; Lacraz Adeline; Yahsou Delmas; Alexandre Cez; Olivier Fritz; Christiane Mousson; Lise Marie Pouteau; Olivier Moranne; Jean-Michel Halimi; Vincent Audard
Journal:  Kidney Int Rep       Date:  2021-05-06

9.  Increased number and activation of peripheral basophils in adult-onset minimal change disease.

Authors:  Huanqin Han; Yong-Zhi Xu; Shuzhen Liao; Haiyan Xiao; Xiaoqun Chen; Xing Lu; Shujun Wang; Chen Yang; Hua-Feng Liu; Qingjun Pan
Journal:  J Cell Mol Med       Date:  2020-06-08       Impact factor: 5.310

10.  Extended infusion of rituximab combined with steroids is effective in inducing remission and reducing relapse in adult minimal change disease.

Authors:  Diankun Liu; Zhanmei Zhou; Mengyi Wang; Sheng Nie; Jun Li; Bianxiang Hu; Wenjuan He; Guobao Wang; Jun Ai
Journal:  BMC Nephrol       Date:  2021-07-01       Impact factor: 2.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.